Table 2. Hazard ratios (HR) and corresponding 95% confidence intervals (CI) associated with polygenic risk score quintiles (Q) compared to the population median, using the Cox proportional hazards model and censored at 20 years after recruitment.
Individuals were categorised into cancer-specific quintiles based on their cancer-specific polygenic risk score (PRS). All models were adjusted for age at recruitment.
Cancer site – gender | Q1 | Q2 | Q3 | Q4 | Q5 |
---|---|---|---|---|---|
Breast – female | |||||
Number of cases | 55 | 73 | 86 | 107 | 145 |
HR (95% CI) | 0.61 (0.44–0.86) | 0.80 (0.59–1.09) | 1.00 (Referent) | 1.25 (0.94–1.66) | 1.64 (1.26–2.14) |
Prostate – male | |||||
Number of cases | 15 | 31 | 55 | 59 | 129 |
HR (95% CI) | 0.28 (0.16–0.50) | 0.57 (0.37–0.88) | 1.00 (Referent) | 1.11 (0.77–1.60) | 2.52 (1.84–3.46) |
Colorectal – female | |||||
Number of cases | 47 | 43 | 53 | 66 | 101 |
HR (95% CI) | 0.84 (0.57–1.25) | 0.80 (0.53–1.20) | 1.00 (Referent) | 1.27 (0.88–1.82) | 1.91 (1.37–2.67) |
Colorectal – male | |||||
Number of cases | 36 | 70 | 71 | 87 | 114 |
HR (95% CI) | 0.51 (0.34–0.77) | 1.00 (0.72–1.39) | 1.00 (Referent) | 1.29 (0.94–1.76) | 1.67 (1.24–2.25) |
Lung – female | |||||
Number of cases | 25 | 26 | 41 | 36 | 40 |
HR (95% CI) | 0.56 (0.34–0.92) | 0.55 (0.34–0.91) | 1.00 (Referent) | 0.89 (0.57–1.39) | 0.95 (0.61–1.47) |
Lung – male | |||||
Number of cases | 51 | 58 | 68 | 80 | 103 |
HR (95% CI) | 0.72 (0.50–1.04) | 0.79 (0.56–1.13) | 1.00 (Referent) | 1.14 (0.82–1.57) | 1.46 (1.07–1.98) |